Compare OCGN & ELVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OCGN | ELVA |
|---|---|---|
| Founded | 2013 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 570.5M | 359.5M |
| IPO Year | 2014 | 2021 |
| Metric | OCGN | ELVA |
|---|---|---|
| Price | $1.80 | $9.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | $9.75 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 8.4M | 274.3K |
| Earning Date | 05-08-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.58 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $34.68 |
| Revenue Next Year | $1,718.38 | $51.48 |
| P/E Ratio | ★ N/A | $78.51 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.64 | $2.46 |
| 52 Week High | $2.73 | $11.88 |
| Indicator | OCGN | ELVA |
|---|---|---|
| Relative Strength Index (RSI) | 46.44 | 66.87 |
| Support Level | $1.51 | $7.10 |
| Resistance Level | $1.93 | $11.67 |
| Average True Range (ATR) | 0.11 | 0.56 |
| MACD | -0.02 | 0.19 |
| Stochastic Oscillator | 26.74 | 99.80 |
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
Electrovaya Inc is a technology-focused lithium-ion battery company engaged in designing, developing and manufacturing battery cells, modules and systems based on its proprietary Infinity Battery Technology, which provides high safety performance, long cycle life and durability. The Company supplies low-voltage and high-voltage battery systems for industrial and transportation markets, including material-handling equipment, robotic vehicles, electric buses and trucks, and energy-storage installations, and its products are suitable for mission-critical applications. it maintains an expanding intellectual-property portfolio, develops next-generation solid-state and hybrid solid-state battery technologies, and sells its products through OEM relationships, dealer networks and direct sales.